IRCT2014041417272N1Completed未知
Comparison of the efficacy of erythropoietin and methyl prednisolone in improving muscle strength or sensory level outcomes in patients with spinal cord injury.
Tabriz University of Medical Sciences, MediCenter for Neuroscience Research0 sites60 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 1 year to 100 years (—)
- Sex
- All
Inclusion Criteria
- •Inclusion Criteria: Patients who develop symptoms of spinal cord injury and decrease muscle strength or sensory level deficit Frankel classification A - E
- •Exclusion criteria: Patients with uncontrolled hypertension, patients allergic to human albumin, Pregnancy and lactation, erythroid leukemia, Patients with a history of thromboembolic events. in patients with severe coronary artery disease , peripheral arteries, the carotidbrain,brain-damaged patients with low GCS due to lack of accurate sensory, motor cases
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Not Applicable
Effect of erythropoietin on outcome of severe brain injured patientsTraumatic brain injury.Diffuse brain injury , Focal brain injuryS06.2 , S0IRCT2013072414138N1Kashan University of Medical Sciences, Deputy of Research60
Recruiting
Phase 3
Evaluating the efficacy of Erythropoietin and Intravenous Iron on transfusion requirements in patients undergoing cardiac surgeryiron deficiency anemia.IRCT20190121042447N1Tehran University of Medical Sciences154
Completed
Phase 3
Erythropoietin efficiency in thalassemiaCondition 1: breast cancer. Condition 2: colon cancer. Condition 3: Rectal cancer. Condition 4: Gastric cancer. Condition 5: Esophageal cancer. Condition 6: Head & Neck cancer. Condition 7: Thalassemia beta minor.Malignant neoplasm of breastMalignant neoplasm of colonMalignant neoplasm of rectumMalignant neoplasm of stomachMalignant neoplasm of esophagusMalignant neoplasm of other and ill-defined sitesThalassemia minorD56.3IRCT20211202053252N1Babol University of Medical Sciences72
Completed
Phase 2
The effect of l-carnitine and erythropoietin on anemia in hemodialysis patientsIRCT20200225046620N1Zahedan University of Medical Sciences24
Completed
Not Applicable
Comparison of the effect of Erythropoietin, L-Carnitine and Erythropoietin plus L-Carnitine in correction of anemia in chronic haemodialysis patientsRenal failureChronic Renal Failure (End-Stage Renal Disease [ESRD])Urological and Genital DiseasesISRCTN96315193Tabriz University of Medical Sciences (Iran)50
